Furthermore, IRE1 also activates ERK1/2 prosurvival signaling [49], and inhibition of the MEK/ERK pathway by U0126 has been shown to sensitize breast cancer cells to ER-induced apoptosis [51]. Here, ESR1 is linked to breast cancer.